Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-19
DOI
10.1038/s41598-020-59853-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer
- (2018) Lydia Meder et al. CANCER RESEARCH
- Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment
- (2018) Dongye Yi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- EphrinB2/EphB4 signaling regulates non‐sprouting angiogenesis by VEGF
- (2018) Elena Groppa et al. EMBO REPORTS
- Platelet-Derived Growth Factor Subunit B Signaling Promotes Pericyte Migration in Response to Loud Sound in the Cochlear Stria Vascularis
- (2018) Zhiqiang Hou et al. JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
- (2018) Joao Incio et al. Science Translational Medicine
- Dual roles of endothelial FGF-2–FGFR1–PDGF-BB and perivascular FGF-2–FGFR2–PDGFRβ signaling pathways in tumor vascular remodeling
- (2018) Kayoko Hosaka et al. Cell Discovery
- NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy
- (2018) Alexandre Dubrac et al. Nature Communications
- Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model
- (2018) Takayuki Kimura et al. CANCER SCIENCE
- Pericytes, an overlooked player in vascular pathobiology
- (2017) David Ferland-McCollough et al. PHARMACOLOGY & THERAPEUTICS
- Non-canonical NOTCH3 signalling limits tumour angiogenesis
- (2017) Shuheng Lin et al. Nature Communications
- Pericyte-expressed Tie2 controls angiogenesis and vessel maturation
- (2017) Martin Teichert et al. Nature Communications
- Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1
- (2017) Hanna M. Eilken et al. Nature Communications
- Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation
- (2017) Nan Wang et al. Scientific Reports
- Tissue Myeloid Progenitors Differentiate into Pericytes through TGF-β Signaling in Developing Skin Vasculature
- (2017) Tomoko Yamazaki et al. Cell Reports
- Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
- (2016) Dong Li et al. CANCER LETTERS
- Pericyte–fibroblast transition promotes tumor growth and metastasis
- (2016) Kayoko Hosaka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutics Targeting FGF Signaling Network in Human Diseases
- (2016) Masaru Katoh TRENDS IN PHARMACOLOGICAL SCIENCES
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma
- (2016) Takuji Torimura et al. NEOPLASIA
- NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma
- (2016) Kou Kayamori et al. PLoS One
- Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
- (2015) Meenal Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
- (2015) Atsushi Mitsuhashi et al. Nature Communications
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake
- (2013) M. Arjaans et al. CANCER RESEARCH
- Aflibercept
- (2013) K. K. Ciombor et al. CLINICAL CANCER RESEARCH
- A Proangiogenic Signature Is Revealed in FGF-Mediated Bevacizumab-Resistant Head and Neck Squamous Cell Carcinoma
- (2013) R. Gyanchandani et al. MOLECULAR CANCER RESEARCH
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
- (2012) Moritz Felcht et al. JOURNAL OF CLINICAL INVESTIGATION
- Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis
- (2012) Frédéric Larrieu-Lahargue et al. PLoS One
- Pericyte-endothelial cell interaction
- (2012) Sharmila Chatterjee et al. Cell Adhesion & Migration
- Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression
- (2011) M. Franco et al. BLOOD
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
- (2011) Yuan Xue et al. NATURE MEDICINE
- Novel EphB4 Monoclonal Antibodies Modulate Angiogenesis and Inhibit Tumor Growth
- (2010) Valery Krasnoperov et al. AMERICAN JOURNAL OF PATHOLOGY
- Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
- (2010) Yingdi Wang et al. NATURE
- E7080, a Multi-Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles
- (2009) K. Ikuta et al. CLINICAL CANCER RESEARCH
- Snail is required for TGF -induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells
- (2008) T. Kokudo et al. JOURNAL OF CELL SCIENCE
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now